<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Severe fever with thrombocytopenia syndrome virus</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Severe fever with thrombocytopenia syndrome virus</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Severe fever with thrombocytopenia syndrome virus</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Myoung-don Oh, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2794382669"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious zoonosis in China and other countries in southeast Asia [<a href="#rid1">1</a>].The causative agent is commonly designated SFTS virus (SFTSV), a newly identified bunyavirus that appears to be carried by ticks (ie, <em>Haemaphysalis longicornis</em>).</p><p class="headingAnchor" id="H6263324"><span class="h1">VIROLOGY</span><span class="headingEndMark"> — </span>SFTSV, or Dabie bandavirus (<em>Bandavirus davieense</em>), is a member of the genus Bandavirus in the family Phenuiviridae and in the order Bunyavirales [<a href="#rid2">2</a>]. The closest relative is Bhanja virus, a tickborne human pathogenic phlebovirus that causes febrile illness and meningitis [<a href="#rid3">3</a>]. Bunyaviruses are largely spherical, enveloped particles with a diameter of 80 to 120 nm. Particles carry three genomic segments designated large (L), medium (M), and small (S).</p><p>The L segment encodes the RNA-dependent RNA polymerase, the M segment the glycoproteins Gn and Gc, and the S segment the nucleoprotein (N) and a nonstructural protein (NSs) using an ambisense coding strategy [<a href="#rid4">4</a>]. The N protein encapsulates the genomic RNA; this complex is further associated with the L protein and forms the active transcriptase/replicase complex. The Gn and Gc glycoproteins form a heterodimer and shape the spikes on the surface of the virion. The glycoproteins mediate receptor binding and virus entry and are the target for neutralizing humoral immune responses [<a href="#rid4">4</a>].</p><p>The C-type lectin, DC-SIGN, has been identified as one of the factors for SFTSV attachment and entry into cells [<a href="#rid5">5</a>]. Glucosylceramide, the glucose-modified lipid, is required for efficient SFTSV entry into cells [<a href="#rid6">6</a>]. The NSs protein serves as a type-I interferon antagonist that suppresses activation of innate immune responses via the IPS-1/IRF-3 and NF-kappaB pathways. SFTSV inhibits exogenous interferon-alpha-induced Jak/STAT signaling through its encoded NSs [<a href="#rid7">7</a>].</p><p>Phylogenetic analysis shows SFTSV can be clustered into six genotypes [<a href="#rid8">8</a>]. SFTSV has been classified into Chinese and Japanese lineages, consistent with the geographical distribution; the two lineages are further divided into six and four sublineages, respectively [<a href="#rid9">9</a>]. At least four different genotypes of SFTSV are cocirculating in South Korea [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H6263331"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>SFTS was first reported in China in 2009 [<a href="#rid11">11</a>]. Since then, cases have emerged from Japan, South Korea, and other countries in eastern Asia. </p><p class="headingAnchor" id="H1713773276"><span class="h2">Cases in China</span><span class="headingEndMark"> — </span>In 2009, SFTS was identified as a new disease in the Huaiyangshan mountain range in China [<a href="#rid12">12-15</a>]. A new virus, designated SFTSV, was isolated from patient blood; the case-fatality rate was 30 percent. In retrospect, SFTS occurred in China as early as 2006, but the cases were misdiagnosed as human granulocytic anaplasmosis. </p><p>Enhanced surveillance using a new case definition and advanced laboratory testing expanded the endemicity zone of SFTSV to neighboring provinces and designated SFTS as a major public health concern in rural eastern China [<a href="#rid12">12-18</a>]. Since 2009, SFTS cases have been identified in central China in the Henan, Hubei, Shandong, Anhui, Zhejiang, Jiangsu, and Liaoning provinces, and endemic areas have expanded from 27 to over 1500 townships [<a href="#rid12">12-14,19,20</a>]. The coastal plains of Dongtai County also have reported cases, but most cases in China are reported in hilly or mountainous areas covered by woods, shrubs, and crops.</p><p>Between 2009 and 2019, the average annual incidence of human SFTS infections in China increased over 20-fold with over 7000 laboratory-confirmed SFTSV cases in total [<a href="#rid12">12,13,20-23</a>]. Cases are reported predominantly between the months of May and August, the peak time of tick and farming activities in China. In reports, cases typically occur in residents ≥60 years of age in rural areas with crop fields and tea farms. Among healthy Chinese individuals, one report noted SFTSV seroprevalence of approximately 4 percent.</p><p class="headingAnchor" id="H66622586"><span class="h2">Cases in countries other than China</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Japan </strong>–<strong> </strong>In 2014, 11 cases of SFTS (including 6 fatalities) were reported in western Japan [<a href="#rid24">24-27</a>]. By August of 2019, 434 cases (including 66 fatalities) had been identified. All patients were from western Japan, and the median age of the patients was 74 years. Most cases occurred between April and August, and many were farmers. Among healthy individuals &gt;50 years of age living in an endemic area in Japan, seroprevalence was 0.14 percent. Phylogenetic analyses indicated that the Japanese SFTSV isolates comprised a genotype independent from those in China, suggesting that the Chinese clade and the Japanese clade may have evolved separately over time. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>South Korea </strong>–<strong> </strong>In South Korea, the first case of SFTS was reported in 2013 [<a href="#rid28">28,29</a>]. By December 2018, 866 patients (including 174 fatal cases) had been confirmed. Most cases occurred between May and October, and the disease was observed in rural areas throughout the country.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other countries </strong>–<strong> </strong>In Vietnam in 2017, a retrospective analysis of blood samples from 80 patients with unexplained acute febrile illness identified two patients who were positive for SFTSV by polymerase chain reaction (PCR) [<a href="#rid30">30-33</a>]. In Myanmar in 2018, 5 of 152 patients suspected of having scrub typhus actually had SFTSV by PCR. In Taiwan in 2019, a case of SFTS was confirmed in a 70-year-old man who had not traveled outside the country. A seroprevalence study in Pakistan in 2016 and 2017 found that 2.5 percent of more than 1600 livestock farmers had micro-neutralizing antibodies against SFTSV. In Thailand, three of over 700 hospitalized patients studied from October 2018 to March 2021 had SFTS with a positive SFTS virus PCR [<a href="#rid34">34</a>]. </p><p></p><p class="headingAnchor" id="H6263338"><span class="h2">Tick vector and transmission of infection</span></p><p class="headingAnchor" id="H3777809591"><span class="h3">Identification of tick vector</span><span class="headingEndMark"> — </span>The primary mode of spread of SFTSV to humans and other animals appears to be via tick bite from the Asian longhorned tick, <em>H</em>.<em> longicornis </em>[<a href="#rid11">11,12,14,35-38</a>]<em>.</em> In prevalence testing of numerous tick species, live virus has only been isolated from <em>H.</em> <em>longicornis </em>ticks. Studies of infected <em>H. longicornis </em>ticks reveal virus in the ticks’ salivary glands, further supporting the capacity of this tick species to transmit the virus. </p><p>Molecular tests such as PCR have detected SFTS viral RNA in multiple other tick species, including <em>H. hystricis</em>, <em>H. flava</em>, <em>Amblyomma testudinarium</em>,<em> Ixodes nipponensis</em>,<em> Rhipicephalus microplus</em>,<em> Dermacentor nuttalli</em>, and <em>Hyalomma asiaticum</em> [<a href="#rid11">11</a>]. Further studies are needed to assess the role of these other species in transmission.</p><p class="headingAnchor" id="H612168492"><span class="h3">Geographic distribution and lifecycle of H. longicornis ticks</span><span class="headingEndMark"> — </span><em>H. longicornis </em>ticks are endemic in southeast Asia, Australia, New Zealand, and several island nations of the western Pacific Region  (<a class="graphic graphic_figure graphicRef135023" href="/d/graphic/135023.html" rel="external">figure 1</a>) [<a href="#rid11">11,39-41</a>]. In 2017 in the United States, the tick was found on a native sheep in New Jersey; since then it has been detected in vegetation and on animals in a wide area of the eastern United States  (<a class="graphic graphic_figure graphicRef134968" href="/d/graphic/134968.html" rel="external">figure 2</a>) [<a href="#rid42">42</a>].</p><p>It is unclear how <em>H. longicornis </em>ticks spread to distant locales [<a href="#rid11">11,43</a>]. Geospatial studies suggest that migratory birds infested with <em>H. longicornis </em>ticks may be responsible for introducing the virus into new regions of Asia [<a href="#rid44">44</a>]. In the United States, the tick species was more likely introduced via importation of domestic pets, horses, or livestock, or on people. The United States Department of Agriculture first detected the ticks on imported quarantined horses and livestock several years before 2017.</p><p>Since 2018, <em>H. longicornis</em> ticks have been designated an invasive species in the United States [<a href="#rid43">43,45</a>]. The tick species has several features that allow it to rapidly establish large populations following introduction to a new location. First, females can lay viable eggs without mating with males; this allows a single female tick to create an entire population of ticks. Additionally, the tick can tolerate a wide range of environmental temperatures and can feed on a wide range of mammalian and avian hosts.</p><p>Adult female ticks must feed on animal hosts before they can lay eggs [<a href="#rid11">11,39,42,46</a>]. In the United States, the tick has been found on wildlife including white-tailed deer and birds, domestic livestock and horses, companion dogs and cats, and humans. The tick is an aggressive biter and can cause massive infestations on animals. </p><p class="headingAnchor" id="H3784129488"><span class="h3">SFTSV in ticks and animals</span><span class="headingEndMark"> — </span>The SFTSV has been found by culture and by PCR in <em>H. longicornis </em>ticks throughout east Asia and the western Pacific islands (see <a class="local">'Identification of tick vector'</a> above). As of 2021, SFTSV has not been detected in ticks in the United States. </p><p><em>H. longicornis </em>ticks become infected with SFTSV by feeding on infected hosts or possibly by maternal transmission [<a href="#rid37">37</a>]. Feeding on infected hosts introduces the infection into the tick population. It is unclear if there is a reservoir host that harbors SFTSV (reservoir hosts are animal species that have a high prevalence of infection and are typically favored meal sources for ticks). Maternal transmission of the virus to tick offspring is suggested by studies of infected ticks that show SFTS viral RNA in the ticks’ ovaries and laid eggs.</p><p>Animal serosurveys in China and South Korea have demonstrated SFTSV-specific antibodies in multiple species such as cattle, goats, sheep, dogs, pigs, chickens, and hedgehogs [<a href="#rid35">35,36,47-50</a>]. In addition, cats have been found to be highly susceptible to SFTSV; high levels of viral RNA have been detected in cats’ serum, eye swabs, and saliva [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H2946942267"><span class="h3">Transmission of SFTSV to humans</span><span class="headingEndMark"> — </span>The primary mode of SFTSV transmission to humans is via the bite of the <em>H. longicornis </em>tick. </p><p>Possible direct transmission from infected cats and dogs to humans via exposure to the animals’ bodily fluids has been reported [<a href="#rid11">11,35,36,39,46-50,52-54</a>].</p><p>Human-to-human transmission via close contact with blood and body secretions has also been reported. For example, family members may be infected during patient care, nosocomial transmission may occur at emergency department and intensive care unit settings, and transmission via needle-stick injury has been reported. In addition, SFTSV RNA has been detected by PCR in semen after disappearance from serum, raising the possibility of sexual transmission [<a href="#rid16">16,55-61</a>].</p><p class="headingAnchor" id="H572862418"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Important factors in the pathogenesis of SFTSV infections likely include high viral load, inflammatory responses similar to systemic inflammatory response syndrome (SIRS), coagulation abnormalities, and multiorgan dysfunction. Uncontrolled upregulation of several cytokines (including interleukin [IL]-1RA, IL-6, IL-10, granulocyte colony-stimulating factor [G-CSF], induced protein [IP]-10, and monocyte chemoattractant protein [MCP]-1) appears to correlate with disease severity, suggesting that SIRS is a significant factor in pathogenesis [<a href="#rid62">62-64</a>]. SFTSV nonstructural protein promotes the hyperinduction of cytokine/chemokine genes [<a href="#rid65">65,66</a>]. SFTSV can infect and replicate in macrophages [<a href="#rid67">67</a>]. SFTSV-infected B cells secrete factors that induce B-cell differentiation into plasmablasts, suggesting that the SFTSV-B cell axis may play an important role in pathogenesis [<a href="#rid68">68</a>]. A unique virus clade (IV) with a specific co-mutation pattern has been associated with a higher case fatality rate (32.9 percent), compared with other three common clades (I, 16.7 percent; II, 13.8 percent; and III, 11.8 percent), suggesting an association between specific viral clades and SFTS mortality [<a href="#rid69">69</a>].</p><p>Autopsy studies have demonstrated that lymph node architecture is replaced with massive necrosis containing histiocytes, immunoblasts, nuclear debris, and eosinophilic ghosts. SFTSV nuclear protein can be detected in the liver, spleen, adrenal, bone marrow, and lymph nodes [<a href="#rid24">24,70,71</a>]. SFTSV-infected cells in lymph nodes are macrophages and class-switched B cells with a similar immunophenotype to that of plasmablasts [<a href="#rid72">72</a>]. </p><p>Hemophagocytes are commonly observed in the bone marrow [<a href="#rid73">73</a>]. In a surviving patient, fludeoxyglucose F 18 positron emission tomography imaging demonstrated hypermetabolism in regional lymph nodes and the spleen [<a href="#rid74">74</a>].</p><p>In animal models of SFTS using C57/BL6 mice and alpha/beta interferon knockout mice, viral replication is most active in the spleen and mesenteric lymph nodes [<a href="#rid75">75,76</a>]. The characteristic histologic findings of the lymph nodes include extensive necrosis and histiocytic proliferation [<a href="#rid77">77</a>]. SFTSV and platelets are colocalized in cytoplasm of macrophages in the spleen. SFTSV adheres to mouse platelets and facilitates their phagocytosis. Splenic clearance of virus-bound, circulating platelets may be important in the pathogenesis of thrombocytopenia in SFTS [<a href="#rid76">76</a>]. </p><p class="headingAnchor" id="H6263345"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Following an incubation period of 7 to 14 days (average 9 days), SFTS begins with a nonspecific prodrome including fever, malaise, headache, myalgia, arthralgia, and dizziness, which persists for about a week. Gastrointestinal manifestations such as nausea, vomiting, and diarrhea are also common [<a href="#rid1">1,12-14,29,36,58,78-83</a>]. SFTSV viral loads peak on days 7 to 10 after fever onset [<a href="#rid84">84</a>].</p><p>Laboratory abnormalities may include leukopenia (&lt;4,000/mm<sup>3</sup>) and thrombocytopenia (&lt;100,000/mm<sup>3</sup>); elevated serum levels of alanine/aspartate aminotransferase, alkaline phosphatase, lactate dehydrogenase, and creatine kinase; and prolongation of activated partial thromboplastin time. SFTSV is also associated with elevated serum ferritin levels [<a href="#rid85">85</a>]. Atypical lymphocytes may appear in the peripheral blood four to eight days after onset of disease [<a href="#rid86">86</a>].</p><p>During the second week of illness, multiorgan dysfunction may develop, including acute kidney injury and cardiac involvement (myocarditis, arrhythmia) [<a href="#rid87">87</a>]. Meningoencephalitis may occur [<a href="#rid88">88</a>]. Bleeding tendency may be observed in the form of mucosal hemorrhage and/or disseminated intravascular coagulation. In surviving patients, these manifestations begin to resolve after 8 to 11 days of illness.</p><p>Invasive pulmonary aspergillosis (IPA) has been observed in 20 to 32 percent of patients hospitalized with SFTS [<a href="#rid89">89,90</a>]. (See  <a class="medical medical_review" href="/d/html/2454.html" rel="external">"Epidemiology and clinical manifestations of invasive aspergillosis", section on 'Pulmonary aspergillosis'</a>.)</p><p>Secondary hemophagocytic lymphohistiocytosis (HLH) has been associated with SFTS, with hyperferritinemia and evidence of hemophagocytosis in the bone marrow. Rapidly deteriorating mental status due to HLH with infiltration of activated lymphocytes and macrophages into the meninges and brain has been described [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis"</a>.)</p><p>Case-fatality rates range from 6 to 21 percent [<a href="#rid20">20,21,29,82</a>]. The time from symptom onset to death is typically 8 to 10 days. </p><p>Poor prognostic factors include longer delay in admission [<a href="#rid92">92</a>], older age, decreased level of consciousness, elevated serum levels of lactate dehydrogenase or aspartate aminotransferase, low lymphocyte percentage, and prolonged activated partial thromboplastin times [<a href="#rid29">29,82,93</a>]. A high level of cell-free DNA at initial presentation, IL-6 and IL-10 levels, and inadequate antibody responses may predict severe illness [<a href="#rid94">94-96</a>]. In a study from China, females had a lower-case fatality rate than males (OR 0.73, 95% CI 0.61–0.87) [<a href="#rid97">97</a>].</p><p class="headingAnchor" id="H6263363"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of SFTSV infection should be suspected in patients with fever, thrombocytopenia, and leukopenia together with a history of tick exposure in an endemic area (central and eastern China, western Japan, and rural areas of South Korea).</p><p>During the first week of illness, a laboratory diagnosis of SFTSV infection may be established by detection of viral RNA in serum via reverse-transcriptase polymerase chain reaction (RT-PCR) or loop-mediated isothermal amplification [<a href="#rid98">98-103</a>].</p><p>During the second and third weeks of illness, a laboratory diagnosis of SFTSV infection may be established by detection of virus-specific immunoglobulin (Ig)M and IgG in serum via enzyme-linked immunosorbent assay using inactivated virus particles or recombinant expressed viral proteins as antigens [<a href="#rid47">47,104,105</a>]. The average time of seroconversion for IgM and IgG is 10 and 17 days, respectively, from symptom onset [<a href="#rid106">106</a>].</p><p class="headingAnchor" id="H3632186586"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of SFTS includes: </p><p class="bulletIndent1"><span class="glyph">●</span>Dengue fever – The cardinal features of dengue hemorrhagic fever include fever, increased vascular permeability, hemorrhagic manifestations, and marked thrombocytopenia (≤100,000 cells/mm<sup>3</sup>). The virus is transmitted by <em>Aedes aegypti</em> mosquitoes, which have broad global distribution; the incubation period is four to seven days. The diagnosis is established via serologic testing. (See  <a class="medical medical_review" href="/d/html/3025.html" rel="external">"Dengue virus infection: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Scrub typhus – Scrub typhus infection is caused by <em>Orientia tsutsugamushi</em> and characterized by fever, headache, anorexia, and malaise; an eschar or rash may develop in a subset of patients. It is transmitted by larval mites (chiggers) in Asia and northern Australia. The incubation period is 6 to 20 days. The diagnosis may be established via serology or polymerase chain reaction (PCR). Altered mental status, leukopenia, thrombocytopenia, and normal C-reactive protein favor SFTS rather than scrub typhus [<a href="#rid107">107,108</a>]. (See  <a class="medical medical_review" href="/d/html/7911.html" rel="external">"Scrub typhus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Candidatus Rickettsia tarasevichiae </em>(CRT) – Human infection with CRT was initially described in northeastern China in 2012, and coinfection with SFTSV may occur [<a href="#rid109">109</a>]. Clinical manifestations include fever, malaise, myalgia, cough, and gastrointestinal symptoms; eschar was observed in a minority of patients. Laboratory manifestations include thrombocytopenia, leukopenia, and elevated levels of lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase. The diagnosis of CRT may be established via PCR.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Kyasanur forest disease (KFD) – KFD is characterized by fever, headache, gastrointestinal symptoms, and bleeding. It is transmitted by ticks or contact with infected animals (incubation period of three to eight days). Infection is endemic in India; cases have been reported in China. The diagnosis is established via PCR, virus isolation from blood, or enzyme-linked immunosorbent serologic assay.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spotted fever <em>Rickettsia </em>– Rickettsial infections are characterized by fever, headache, and myalgia, often in association with a rash and/or eschar. They are usually transmitted by ticks with an incubation period of 2 to 14 days and span a broad geographic distribution. The diagnosis may be established via serology or PCR. (See  <a class="medical medical_review" href="/d/html/7908.html" rel="external">"Other spotted fever group rickettsial infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhagic fever with renal syndrome (HFRS) – HFRS is caused by hantavirus infection; it is characterized by fever, hemorrhage, hypotension, renal failure, and thrombocytopenia. It is transmitted by contact with or inhalation of aerosolized rodent urine or feces. Infection occurs worldwide, including Asia, Europe, and the Americas. The diagnosis is established via serology. (See  <a class="medical medical_review" href="/d/html/7240.html" rel="external">"Kidney involvement in hantavirus infections"</a> and  <a class="medical medical_review" href="/d/html/8307.html" rel="external">"Epidemiology and diagnosis of hantavirus infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Crimean-Congo hemorrhagic fever (CCHF) – CCHF is characterized by fever and hemorrhage. It is transmitted by ticks (incubation period of 1 to 9 days) or contact with infected humans or rodents (incubation period of 3 to 13 days) and is endemic in parts of southern Europe, the Middle East, Africa, and northwestern China. The diagnosis is established via reverse-transcriptase polymerase chain reaction (RT-PCR) or serology. (See  <a class="medical medical_review" href="/d/html/102363.html" rel="external">"Crimean-Congo hemorrhagic fever"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other hemorrhagic fevers – Other hemorrhagic fevers, such as Ebola and Marburg, may be difficult to distinguish from SFTSV based on symptoms but may be excluded by geography (both are endemic to Africa). (See  <a class="medical medical_review" href="/d/html/3022.html" rel="external">"Clinical manifestations and diagnosis of Ebola virus disease"</a> and  <a class="medical medical_review" href="/d/html/98084.html" rel="external">"Marburg virus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Leptospirosis – Leptospirosis is characterized by fever, rigors, myalgia, conjunctival suffusion, and headache. Less common symptoms and signs include cough, nausea, vomiting, diarrhea, abdominal pain, and jaundice. It is transmitted via exposure to animal urine or contaminated water or soil and occurs worldwide, particularly south and Southeast Asia and South America. The diagnosis is established via serology. (See  <a class="medical medical_review" href="/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ehrlichiosis and anaplasmosis – Clinical manifestations of ehrlichiosis and anaplasmosis include fever, chills, malaise, myalgia, and headache; laboratory manifestations include leukopenia, thrombocytopenia, and elevated serum aminotransferase levels. The diagnosis is established via indirect fluorescent antibody test. (See  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heartland virus disease – Heartland virus, or Heartland bandavirus, is a likely tickborne virus associated with nonspecific symptoms and signs (fever, anorexia, headache, confusion, nausea, and myalgias and/or arthralgias); it has been observed primarily in the midwestern and southeastern United States. The diagnosis may be established via serologic studies and/or real-time RT-PCR. (See  <a class="medical medical_review" href="/d/html/103772.html" rel="external">"Emerging viruses", section on 'Heartland virus disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemophagocytic lymphohistiocytosis (HLH) – HLH is syndrome of excessive immune activation; it is often associated with viral infections, including SFTS. Common findings include fever, hepatosplenomegaly, rash, lymphadenopathy, neurologic symptoms, cytopenias, high serum ferritin, and liver function abnormalities. The diagnosis is established by diagnostic criteria as summarized separately. (See  <a class="medical medical_review" href="/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Langya henipavirus (LayV) infection – Langya henipavirus is a novel zoonotic virus identified in febrile patients in China. Common symptoms and laboratory abnormalities include fever, fatigue, cough, anorexia, myalgia, leukopenia, and thrombocytopenia. Six of the 35 patients with LayV infection also had SFTSV infection [<a href="#rid110">110</a>].</p><p></p><p class="headingAnchor" id="H6263370"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>There is no antiviral therapy available for treatment of SFTS; management consists of supportive care. Early recognition of severe disease and complication is important. </p><p>Use of <a class="drug drug_general" data-topicid="9860" href="/d/drug information/9860.html" rel="external">ribavirin</a> for treatment of patients with SFTS has been described, but there is no convincing evidence for a therapeutic effect [<a href="#rid92">92,111</a>]. Favipiravir, a pyrazine derivative, has stronger antiviral activity than that of ribavirin in vitro and in a mouse model [<a href="#rid112">112,113</a>]. A study of favipiravir in 23 SFTS patients in Japan found lower mortality rates compared to other case series of SFTS patients in Japan, but adverse events, including elevated hepatic enzymes, were more frequent [<a href="#rid114">114</a>]. In an investigator-initiated, single-blind, randomized controlled trial in China, fatal outcomes occurred in 9.5 percent (7 of 74) of favipiravir-treated patients and 18.3 percent (13 of 71) of controls (OR, 0.466; 95% CI, 0.17–1.25). The dosage of favipiravir in the trial was lower than that used for treating Ebola virus disease, and severe adverse events were not observed [<a href="#rid115">115</a>]. Some data suggest that favipiravir may more beneficial for patients ≤70 years of age compared with patients over 70 [<a href="#rid116">116</a>]. Although preliminary data with favipiravir are promising, more data from carefully controlled trials are necessary.</p><p>In areas where anaplasmosis and scrub typhus are endemic, empiric treatment with <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> for these infections may be reasonable until diagnostic test results are available. Coinfection of SFTS and scrub typhus or <em>Rickettsia japonica </em>may occur [<a href="#rid33">33,117-119</a>]. (See <a class="local">'Differential diagnosis'</a> above.) </p><p>Bleeding complications should be managed via transfusion of fresh frozen plasma or fresh whole blood, guided by international normalized ratio/prothrombin time [<a href="#rid120">120</a>]. Some reports suggest that plasma exchange may be beneficial [<a href="#rid121">121-123</a>]; controlled clinical trials are needed. Based on limited data, steroid treatment does not appear to improve prognosis and may increase complications, including secondary infections like invasive aspergillosis [<a href="#rid124">124-126</a>].</p><p>Early diagnosis and treatment of invasive pulmonary aspergillosis are important [<a href="#rid90">90,127,128</a>]. (See  <a class="medical medical_review" href="/d/html/15717.html" rel="external">"Diagnosis of invasive aspergillosis"</a> and  <a class="medical medical_review" href="/d/html/2459.html" rel="external">"Treatment and prevention of invasive aspergillosis"</a>.) </p><p class="headingAnchor" id="H1268501525"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>There is no vaccine available for prevention of SFTS. Individuals in areas with risk for transmission should take measures to avoid tick bites. (See  <a class="medical medical_review" href="/d/html/4085.html" rel="external">"Prevention of arthropod and insect bites: Repellents and other measures"</a>.)</p><p>Standard precautions should be implemented while taking care of patients with suspected SFTS. Patient rooms should be disinfected after discharge [<a href="#rid129">129</a>]. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection"</a>.)</p><p>In endemic areas, direct contact with bodily fluids of cats, particularly those that are sick, should be avoided [<a href="#rid51">51,52</a>].</p><p class="headingAnchor" id="H6263377"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Severe fever with thrombocytopenia syndrome (SFTS), also known as fever, thrombocytopenia, and leukopenia syndrome, is an emerging tickborne infection. The causative agent is a bunyavirus, commonly designated SFTS virus (SFTSV). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> (see <a class="local">'Epidemiology'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Human cases </strong>– Since 2009, human cases of SFTS have been reported in China, Japan, South Korea, and other countries in eastern Asia. (See <a class="local">'Cases in China'</a> above and <a class="local">'Cases in countries other than China'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Transmission to humans </strong>– The primary mode of spread of SFTSV to humans is via a bite from the Asian longhorned tick, <em>Haemaphysalis longicornis</em>. Possible direct transmission from infected cats and dogs to humans has been reported, as has human-to-human spread via close contact to blood and body secretions. (See <a class="local">'Transmission of SFTSV to humans'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tick vector </strong>– The <em>H. longicornis </em>tick is found throughout southeast Asia and the islands of the western Pacific, as well as in the United States. SFTSV has been detected in <em>H. longicornis </em>ticks throughout eastern Asia. As of 2021, the virus has not been detected in ticks in the United States. (See <a class="local">'Geographic distribution and lifecycle of H. longicornis ticks'</a> above and <a class="local">'SFTSV in ticks and animals'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> (see <a class="local">'Clinical manifestations'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical presentation</strong> – Following an incubation period of 7 to 14 days, patients develop fever, headache, myalgia, and arthralgia, sometimes accompanied by vomiting and diarrhea. During the second week of illness, some individuals develop mucosal hemorrhage, hemorrhagic rash, altered mental status with or without meningoencephalitis, and multiorgan failure.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory findings </strong>–<strong> </strong>Laboratory findings include leukopenia and thrombocytopenia. Some cases have elevated liver enzymes, lactate dehydrogenase, and creatine kinase, as well as disseminated intravascular coagulopathy. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complications </strong>–<strong> </strong>Invasive pulmonary aspergillosis has been observed in 20 to 32 percent of hospitalized patients with SFTS. Secondary hemophagocytic lymphohistiocytosis (HLH) has also been reported.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>–<strong> </strong>SFTSV infection should be suspected in patients with fever, thrombocytopenia, and leukopenia together with a history of tick exposure in an endemic area. Laboratory diagnosis is based on serum polymerase chain reaction (PCR; during the first week of illness) or antibody detection (during the second or third week of illness). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment and prevention </strong>–<strong> </strong>Treatment consists of supportive care. There is no antiviral therapy available for treatment of SFTSV, and no vaccine is available for prevention of SFTSV. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mortality </strong>– Case-fatality rates range from 6 to 21 percent. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="headingAnchor" id="H1663890230"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Hideki Ebihara, PhD, and Heinz Feldmann, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Liu Q, He B, Huang SY, et al. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis 2014; 14:763.</a></li><li class="breakAll">Taxon Details. International Committee on Taxonomy of Viruses. Available at: https://ictv.global/taxonomy/taxondetails?taxnode_id=20141803&amp;src=NCBI&amp;ictv_id=20141803 (Accessed on July 10, 2023).</li><li><a class="nounderline abstract_t">Matsuno K, Weisend C, Travassos da Rosa AP, et al. Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses. J Virol 2013; 87:3719.</a></li><li class="breakAll">Plyusnin A, Beaty BJ, Elliott RM, et al. Bunyaviridae. In: Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (Eds), Elsevier Academic Press, London 2011. p.725.</li><li><a class="nounderline abstract_t">Hofmann H, Li X, Zhang X, et al. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J Virol 2013; 87:4384.</a></li><li><a class="nounderline abstract_t">Drake MJ, Brennan B, Briley K Jr, et al. A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry. PLoS Pathog 2017; 13:e1006316.</a></li><li><a class="nounderline abstract_t">Chen X, Ye H, Li S, et al. Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs invitro. PLoS One 2017; 12:e0172744.</a></li><li><a class="nounderline abstract_t">Fu Y, Li S, Zhang Z, et al. Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands, China: implication for transmission across the ocean. Sci Rep 2016; 6:19563.</a></li><li><a class="nounderline abstract_t">Lv Q, Zhang H, Tian L, et al. Novel sub-lineages, recombinants and reassortants of severe fever with thrombocytopenia syndrome virus. Ticks Tick Borne Dis 2017; 8:385.</a></li><li><a class="nounderline abstract_t">Yun SM, Park SJ, Park SW, et al. Molecular genomic characterization of tick- and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea. PLoS Negl Trop Dis 2017; 11:e0005893.</a></li><li><a class="nounderline abstract_t">Casel MA, Park SJ, Choi YK. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy. Exp Mol Med 2021; 53:713.</a></li><li><a class="nounderline abstract_t">Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011; 364:1523.</a></li><li><a class="nounderline abstract_t">Xu B, Liu L, Huang X, et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog 2011; 7:e1002369.</a></li><li><a class="nounderline abstract_t">Zhang YZ, Zhou DJ, Xiong Y, et al. Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32:209.</a></li><li><a class="nounderline abstract_t">Feldmann H. Truly emerging--a new disease caused by a novel virus. N Engl J Med 2011; 364:1561.</a></li><li><a class="nounderline abstract_t">Bao CJ, Guo XL, Qi X, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 2011; 53:1208.</a></li><li><a class="nounderline abstract_t">Zhang L, Liu Y, Ni D, et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA 2008; 300:2263.</a></li><li><a class="nounderline abstract_t">Cui F, Cao HX, Wang L, et al. Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China. Am J Trop Med Hyg 2013; 88:510.</a></li><li><a class="nounderline abstract_t">Hu J, Li Z, Cai J, et al. A Cluster of Bunyavirus-Associated Severe Fever With Thrombocytopenia Syndrome Cases in a Coastal Plain Area in China, 2015: Identification of a Previously Unidentified Endemic Region for Severe Fever With Thrombocytopenia Bunyavirus. Open Forum Infect Dis 2019; 6:ofz209.</a></li><li><a class="nounderline abstract_t">Miao D, Liu MJ, Wang YX, et al. Epidemiology and Ecology of Severe Fever With Thrombocytopenia Syndrome in China, 2010‒2018. Clin Infect Dis 2021; 73:e3851.</a></li><li><a class="nounderline abstract_t">Sun J, Lu L, Wu H, et al. The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011-2016. Sci Rep 2017; 7:9236.</a></li><li><a class="nounderline abstract_t">Zhan J, Wang Q, Cheng J, et al. Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin 2017; 32:51.</a></li><li><a class="nounderline abstract_t">Li P, Tong ZD, Li KF, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis. PLoS One 2017; 12:e0175592.</a></li><li><a class="nounderline abstract_t">Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis 2014; 209:816.</a></li><li><a class="nounderline abstract_t">Yoshikawa T, Shimojima M, Fukushi S, et al. Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan. J Infect Dis 2015; 212:889.</a></li><li class="breakAll">National Institute of Infectious Diseases. Severe febrile thrombocytopenic syndrome (SFTS). https://www.niid.go.jp/niid/ja/diseases/sa/sfts.html (Accessed on August 01, 2019).</li><li><a class="nounderline abstract_t">Kimura T, Fukuma A, Shimojima M, et al. Seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) virus antibodies in humans and animals in Ehime prefecture, Japan, an endemic region of SFTS. J Infect Chemother 2018; 24:802.</a></li><li><a class="nounderline abstract_t">Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis 2013; 19:1892.</a></li><li><a class="nounderline abstract_t">Choi SJ, Park SW, Bae IG, et al. Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015. PLoS Negl Trop Dis 2016; 10:e0005264.</a></li><li><a class="nounderline abstract_t">Tran XC, Yun Y, Van An L, et al. Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam. Emerg Infect Dis 2019; 25:1029.</a></li><li><a class="nounderline abstract_t">Peng SH, Yang SL, Tang SE, et al. Human Case of Severe Fever with Thrombocytopenia Syndrome Virus Infection, Taiwan, 2019. Emerg Infect Dis 2020; 26:1612.</a></li><li><a class="nounderline abstract_t">Zohaib A, Zhang J, Saqib M, et al. Serologic Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and Related Viruses in Pakistan. Emerg Infect Dis 2020; 26:1513.</a></li><li><a class="nounderline abstract_t">Win AM, Nguyen YTH, Kim Y, et al. Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar. Emerg Infect Dis 2020; 26:1878.</a></li><li><a class="nounderline abstract_t">Rattanakomol P, Khongwichit S, Linsuwanon P, et al. Severe Fever with Thrombocytopenia Syndrome Virus Infection, Thailand, 2019-2020. Emerg Infect Dis 2022; 28:2572.</a></li><li><a class="nounderline abstract_t">Jiang XL, Wang XJ, Li JD, et al. [Isolation, identification and characterization of SFTS bunyavirus from ticks collected on the surface of domestic animals]. Bing Du Xue Bao 2012; 28:252.</a></li><li><a class="nounderline abstract_t">Liu Y, Huang XY, Du YH, et al. [Survey on ticks and detection of new bunyavirus in some vect in the endemic areas of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan province]. Zhonghua Yu Fang Yi Xue Za Zhi 2012; 46:500.</a></li><li><a class="nounderline abstract_t">Zhuang L, Sun Y, Cui XM, et al. Transmission of Severe Fever with Thrombocytopenia Syndrome Virus by Haemaphysalis longicornis Ticks, China. Emerg Infect Dis 2018; 24.</a></li><li><a class="nounderline abstract_t">Sato Y, Mekata H, Sudaryatma PE, et al. Isolation of Severe Fever with Thrombocytopenia Syndrome Virus from Various Tick Species in Area with Human Severe Fever with Thrombocytopenia Syndrome Cases. Vector Borne Zoonotic Dis 2021; 21:378.</a></li><li><a class="nounderline abstract_t">Beard CB, Occi J, Bonilla DL, et al. Multistate Infestation with the Exotic Disease-Vector Tick Haemaphysalis longicornis - United States, August 2017-September 2018. MMWR Morb Mortal Wkly Rep 2018; 67:1310.</a></li><li><a class="nounderline abstract_t">Zhao L, Li J, Cui X, et al. Distribution of Haemaphysalis longicornis and associated pathogens: analysis of pooled data from a China field survey and global published data. Lancet Planet Health 2020; 4:e320.</a></li><li><a class="nounderline abstract_t">Jia N, Wang J, Shi W, et al. Haemaphysalis longicornis. Trends Genet 2021; 37:292.</a></li><li class="breakAll">United States Department of Agriculture. National Haemaphysalis longicornis (Asian longhorned tick) situation report. http://www.aphis.usda.gov/animal_health/animal_diseases/tick/downloads/longhorned-tick-sitrep.pdf (Accessed on January 20, 2022).</li><li><a class="nounderline abstract_t">Tufts DM, VanAcker MC, Fernandez MP, et al. Distribution, Host-Seeking Phenology, and Host and Habitat Associations of Haemaphysalis longicornis Ticks, Staten Island, New York, USA. Emerg Infect Dis 2019; 25:792.</a></li><li><a class="nounderline abstract_t">Zhang X, Zhao C, Cheng C, et al. Rapid Spread of Severe Fever with Thrombocytopenia Syndrome Virus by Parthenogenetic Asian Longhorned Ticks. Emerg Infect Dis 2022; 28:363.</a></li><li class="breakAll">United States Department of Agriculture, National Invasive Species Information Center. Asian longhorned tick. https://www.invasivespeciesinfo.gov/terrestrial/invertebrates/asian-longhorned-tick#cit (Accessed on January 20, 2022).</li><li><a class="nounderline abstract_t">Wormser GP, McKenna D, Piedmonte N, et al. First Recognized Human Bite in the United States by the Asian Longhorned Tick, Haemaphysalis longicornis. Clin Infect Dis 2020; 70:314.</a></li><li><a class="nounderline abstract_t">Jiao Y, Zeng X, Guo X, et al. Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50:372.</a></li><li><a class="nounderline abstract_t">Wang T, Li XL, Liu M, et al. Epidemiological Characteristics and Environmental Risk Factors of Severe Fever with Thrombocytopenia Syndrome in Hubei Province, China, from 2011 to 2016. Front Microbiol 2017; 8:387.</a></li><li><a class="nounderline abstract_t">Chen C, Li P, Li KF, et al. Animals as amplification hosts in the spread of severe fever with thrombocytopenia syndrome virus: A systematic review and meta-analysis. Int J Infect Dis 2019; 79:77.</a></li><li><a class="nounderline abstract_t">Kang JG, Cho YK, Jo YS, et al. Severe Fever with Thrombocytopenia Syndrome Virus in Dogs, South Korea. Emerg Infect Dis 2019; 25:376.</a></li><li><a class="nounderline abstract_t">Park ES, Shimojima M, Nagata N, et al. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats. Sci Rep 2019; 9:11990.</a></li><li><a class="nounderline abstract_t">Kida K, Matsuoka Y, Shimoda T, et al. A Case of Cat-to-Human Transmission of Severe Fever with Thrombocytopenia Syndrome Virus. Jpn J Infect Dis 2019; 72:356.</a></li><li><a class="nounderline abstract_t">Chung JK, Kim CM, Kim DM, et al. Severe Fever with Thrombocytopenia Syndrome Associated with Manual De-Ticking of Domestic Dogs. Vector Borne Zoonotic Dis 2020; 20:285.</a></li><li><a class="nounderline abstract_t">Kobayashi Y, Kato H, Yamagishi T, et al. Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017. Emerg Infect Dis 2020; 26:692.</a></li><li><a class="nounderline abstract_t">Zhu Y, Wu H, Gao J, et al. Two confirmed cases of severe fever with thrombocytopenia syndrome with pneumonia: implication for a family cluster in East China. BMC Infect Dis 2017; 17:537.</a></li><li><a class="nounderline abstract_t">Chen H, Hu K, Zou J, Xiao J. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. Int J Infect Dis 2013; 17:e206.</a></li><li><a class="nounderline abstract_t">Liu Y, Li Q, Hu W, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis 2012; 12:156.</a></li><li><a class="nounderline abstract_t">Gai Z, Liang M, Zhang Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact. Clin Infect Dis 2012; 54:249.</a></li><li><a class="nounderline abstract_t">Kim WY, Choi W, Park SW, et al. Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea. Clin Infect Dis 2015; 60:1681.</a></li><li><a class="nounderline abstract_t">Chen Y, Jia B, Huang R, et al. Occupational Severe Fever With Thrombocytopenia Syndrome Following Needle-Stick Injury. Infect Control Hosp Epidemiol 2017; :1.</a></li><li><a class="nounderline abstract_t">Koga S, Takazono T, Ando T, et al. Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan. Emerg Infect Dis 2019; 25:2127.</a></li><li><a class="nounderline abstract_t">Deng B, Zhang S, Geng Y, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One 2012; 7:e41365.</a></li><li><a class="nounderline abstract_t">Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis 2012; 206:1085.</a></li><li><a class="nounderline abstract_t">Hu LF, Wu T, Wang B, et al. The Regulation of Seventeen Inflammatory Mediators are Associated with Patient Outcomes in Severe Fever with Thrombocytopenia Syndrome. Sci Rep 2018; 8:159.</a></li><li><a class="nounderline abstract_t">Khalil J, Yamada S, Tsukamoto Y, et al. The Nonstructural Protein NSs of Severe Fever with Thrombocytopenia Syndrome Virus Causes a Cytokine Storm through the Hyperactivation of NF-κB. Mol Cell Biol 2021; 41:e0054220.</a></li><li><a class="nounderline abstract_t">Bryden SR, Dunlop JI, Clarke AT, et al. Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model. PNAS Nexus 2022; 1:pgac024.</a></li><li><a class="nounderline abstract_t">Zhang L, Fu Y, Wang H, et al. Severe Fever With Thrombocytopenia Syndrome Virus-Induced Macrophage Differentiation Is Regulated by miR-146. Front Immunol 2019; 10:1095.</a></li><li><a class="nounderline abstract_t">Wada Y, Miyamoto S, Iida S, et al. Propagation of Activated B Cells by In Vitro Severe Fever With Thrombocytopenia Syndrome Virus Infection of Human Peripheral Blood Mononuclear Cells. J Infect Dis 2022; 225:269.</a></li><li><a class="nounderline abstract_t">Dai ZN, Peng XF, Li JC, et al. Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality. Emerg Microbes Infect 2022; 11:1672.</a></li><li><a class="nounderline abstract_t">Uehara N, Yano T, Ishihara A, et al. Fatal Severe Fever with Thrombocytopenia Syndrome: An Autopsy Case Report. Intern Med 2016; 55:831.</a></li><li><a class="nounderline abstract_t">Hiraki T, Yoshimitsu M, Suzuki T, et al. Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS. Pathol Int 2014; 64:569.</a></li><li><a class="nounderline abstract_t">Suzuki T, Sato Y, Sano K, et al. Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections. J Clin Invest 2020; 130:799.</a></li><li><a class="nounderline abstract_t">Kim N, Kim KH, Lee SJ, et al. Bone marrow findings in severe fever with thrombocytopenia syndrome: prominent haemophagocytosis and its implication in haemophagocytic lymphohistiocytosis. J Clin Pathol 2016; 69:537.</a></li><li><a class="nounderline abstract_t">Kang CK, Choi SJ, Koh J, et al. 18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome. Ticks Tick Borne Dis 2018; 9:972.</a></li><li><a class="nounderline abstract_t">Liu Y, Wu B, Paessler S, et al. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J Virol 2014; 88:1781.</a></li><li><a class="nounderline abstract_t">Jin C, Liang M, Ning J, et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A 2012; 109:10053.</a></li><li><a class="nounderline abstract_t">Matsuno K, Orba Y, Maede-White K, et al. Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection. Front Microbiol 2017; 8:104.</a></li><li><a class="nounderline abstract_t">Zhang L, Wang X, Zhang Y, et al. Severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) infections in Zhejiang Province, China. Int J Infect Dis 2013; 17:e137.</a></li><li><a class="nounderline abstract_t">Zhang YZ, He YW, Dai YA, et al. Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 2012; 54:527.</a></li><li><a class="nounderline abstract_t">Gai ZT, Zhang Y, Liang MF, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis 2012; 206:1095.</a></li><li><a class="nounderline abstract_t">Wen HL, Zhao L, Zhai S, et al. Severe fever with thrombocytopenia syndrome, Shandong Province, China, 2011. Emerg Infect Dis 2014; 20:1.</a></li><li><a class="nounderline abstract_t">Kato H, Yamagishi T, Shimada T, et al. Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014. PLoS One 2016; 11:e0165207.</a></li><li><a class="nounderline abstract_t">Guo CT, Lu QB, Ding SJ, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis. Epidemiol Infect 2016; 144:1345.</a></li><li><a class="nounderline abstract_t">Liu J, Wang L, Feng Z, et al. Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients. Int J Infect Dis 2017; 58:45.</a></li><li><a class="nounderline abstract_t">Kim UJ, Oh TH, Kim B, et al. Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome. Dis Markers 2017; 2017:6727184.</a></li><li><a class="nounderline abstract_t">Takahashi T, Suzuki T, Hiroshige S, et al. Transient Appearance of Plasmablasts in the Peripheral Blood of Japanese Patients With Severe Fever With Thrombocytopenia Syndrome. J Infect Dis 2019; 220:23.</a></li><li><a class="nounderline abstract_t">Miyamoto S, Ito T, Terada S, et al. Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report. BMC Infect Dis 2019; 19:266.</a></li><li><a class="nounderline abstract_t">Park SY, Kwon JS, Kim JY, et al. Severe fever with thrombocytopenia syndrome-associated encephalopathy/encephalitis. Clin Microbiol Infect 2018; 24:432.e1.</a></li><li><a class="nounderline abstract_t">Bae S, Hwang HJ, Kim MY, et al. Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome. Clin Infect Dis 2020; 70:1491.</a></li><li><a class="nounderline abstract_t">Xu Y, Shao M, Liu N, et al. Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study. Int J Infect Dis 2021; 105:646.</a></li><li><a class="nounderline abstract_t">Kaneko M, Shikata H, Matsukage S, et al. A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system. J Infect Chemother 2018; 24:292.</a></li><li><a class="nounderline abstract_t">Li H, Lu QB, Xing B, et al. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study. Lancet Infect Dis 2018; 18:1127.</a></li><li><a class="nounderline abstract_t">Wang L, Wan G, Shen Y, et al. A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China. PLoS Negl Trop Dis 2019; 13:e0007829.</a></li><li><a class="nounderline abstract_t">Zhang Y, Song R, Shen Y, et al. High Levels of Circulating Cell-free DNA Are Associated With a Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome. Clin Infect Dis 2020; 70:1941.</a></li><li><a class="nounderline abstract_t">Yoo JR, Kim TJ, Heo ST, et al. IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South Korea. Front Immunol 2021; 12:711847.</a></li><li><a class="nounderline abstract_t">Kwon JS, Jin S, Kim JY, et al. Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea. Viruses 2021; 13.</a></li><li><a class="nounderline abstract_t">Qian J, Wei J, Ren L, et al. Sex differences in incidence and fatality of severe fever with thrombocytopenia syndrome: A comparative study based on national surveillance data of China. J Med Virol 2023; 95:e28632.</a></li><li><a class="nounderline abstract_t">Cui L, Ge Y, Qi X, et al. Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization. J Clin Microbiol 2012; 50:3881.</a></li><li><a class="nounderline abstract_t">Sun Y, Liang M, Qu J, et al. Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Virol 2012; 53:48.</a></li><li><a class="nounderline abstract_t">Yang G, Li B, Liu L, et al. Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for rapid detection of a new SFTS bunyavirus. Arch Virol 2012; 157:1779.</a></li><li><a class="nounderline abstract_t">Li Z, Cui L, Zhou M, et al. Development and application of a one-step real-time RT-PCR using a minor-groove-binding probe for the detection of a novel bunyavirus in clinical specimens. J Med Virol 2013; 85:370.</a></li><li><a class="nounderline abstract_t">Yoshikawa T, Fukushi S, Tani H, et al. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J Clin Microbiol 2014; 52:3325.</a></li><li><a class="nounderline abstract_t">Sano S, Fukushi S, Yamada S, et al. Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus. Viruses 2021; 13.</a></li><li><a class="nounderline abstract_t">Lu J, Li C, Zhang FS, et al. [Expression of structural and non-structural proteins of severe fever with thrombocytopenia syndrome bunyavirus]. Bing Du Xue Bao 2011; 27:515.</a></li><li><a class="nounderline abstract_t">Yu L, Zhang L, Sun L, et al. Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies. PLoS One 2012; 7:e38291.</a></li><li><a class="nounderline abstract_t">Hu L, Kong Q, Liu Y, et al. Time Course of Severe Fever With Thrombocytopenia Syndrome Virus and Antibodies in Patients by Long-Term Follow-Up Study, China. Front Microbiol 2021; 12:744037.</a></li><li><a class="nounderline abstract_t">Kim MC, Chong YP, Lee SO, et al. Differentiation of Severe Fever With Thrombocytopenia Syndrome From Scrub Typhus. Clin Infect Dis 2018; 66:1621.</a></li><li><a class="nounderline abstract_t">Park SW, Lee CS, Kim JH, et al. Severe fever with thrombocytopenia syndrome: comparison with scrub typhus and clinical diagnostic prediction. BMC Infect Dis 2019; 19:174.</a></li><li><a class="nounderline abstract_t">Liu W, Li H, Lu QB, et al. Candidatus Rickettsia tarasevichiae Infection in Eastern Central China: A Case Series. Ann Intern Med 2016; 164:641.</a></li><li><a class="nounderline abstract_t">Zhang XA, Li H, Jiang FC, et al. A Zoonotic Henipavirus in Febrile Patients in China. N Engl J Med 2022; 387:470.</a></li><li><a class="nounderline abstract_t">Liu W, Lu QB, Cui N, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis 2013; 57:1292.</a></li><li><a class="nounderline abstract_t">Tani H, Fukuma A, Fukushi S, et al. Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus. mSphere 2016; 1.</a></li><li><a class="nounderline abstract_t">Tani H, Komeno T, Fukuma A, et al. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS One 2018; 13:e0206416.</a></li><li><a class="nounderline abstract_t">Suemori K, Saijo M, Yamanaka A, et al. A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis 2021; 15:e0009103.</a></li><li><a class="nounderline abstract_t">Li H, Jiang XM, Cui N, et al. Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome. Signal Transduct Target Ther 2021; 6:145.</a></li><li><a class="nounderline abstract_t">Yuan Y, Lu QB, Yao WS, et al. Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome. EBioMedicine 2021; 72:103591.</a></li><li><a class="nounderline abstract_t">Wi YM, Woo HI, Park D, et al. Severe Fever with Thrombocytopenia Syndrome in Patients Suspected of Having Scrub Typhus. Emerg Infect Dis 2016; 22:1992.</a></li><li><a class="nounderline abstract_t">Ra SH, Kim JY, Cha HH, et al. Coinfection of Severe Fever with Thrombocytopenia Syndrome and Scrub Typhus in Patients with Tick-Borne Illness. Am J Trop Med Hyg 2019; 101:1259.</a></li><li><a class="nounderline abstract_t">Fujikawa T, Yoshikawa T, Kurosu T, et al. Co-infection with Severe Fever with Thrombocytopenia Syndrome Virus and Rickettsia japonica after Tick Bite, Japan. Emerg Infect Dis 2021; 27:1247.</a></li><li class="breakAll">World Health Organization. Clinical management of patients with viral haemorrhagic fever: A pocket guide for front-line health workers. http://apps.who.int/iris/bitstream/handle/10665/205570/9789241549608_eng.pdf (Accessed on May 09, 2018).</li><li><a class="nounderline abstract_t">Oh WS, Yoo JR, Kwon KT, et al. Effect of Early Plasma Exchange on Survival in Patients with Severe Fever with Thrombocytopenia Syndrome: A Multicenter Study. Yonsei Med J 2017; 58:867.</a></li><li><a class="nounderline abstract_t">Park I, Kim HI, Kwon KT. Two Treatment Cases of Severe Fever and Thrombocytopenia Syndrome with Oral Ribavirin and Plasma Exchange. Infect Chemother 2017; 49:72.</a></li><li><a class="nounderline abstract_t">Yoo JR, Kim SH, Kim YR, et al. Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome. Korean J Intern Med 2019; 34:902.</a></li><li><a class="nounderline abstract_t">Kutsuna S, Ohbe H, Matsui H, Yasunaga H. Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: Retrospective analysis with overlap weighting using a national inpatient database. J Infect Chemother 2023; 29:490.</a></li><li><a class="nounderline abstract_t">Jung SI, Kim YE, Yun NR, et al. Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study. PLoS Negl Trop Dis 2021; 15:e0009128.</a></li><li><a class="nounderline abstract_t">Kawaguchi T, Umekita K, Yamanaka A, et al. Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case-Control Study. Viruses 2021; 13.</a></li><li><a class="nounderline abstract_t">Iwao K, Kawaguchi T, Kimura M, et al. Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case. Viruses 2021; 13.</a></li><li><a class="nounderline abstract_t">Zuo Y, Wang H, Huang J, et al. Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study. J Med Virol 2023; 95:e28712.</a></li><li><a class="nounderline abstract_t">Ryu BH, Kim JY, Kim T, et al. Extensive severe fever with thrombocytopenia syndrome virus contamination in surrounding environment in patient rooms. Clin Microbiol Infect 2018; 24:911.e1.</a></li></ol></div><div id="topicVersionRevision">Topic 88736 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24837566" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24837566" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23325688" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23325688" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23388721" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28388693" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28234991" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs invitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26806841" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands, China: implication for transmission across the ocean.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28117273" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Novel sub-lineages, recombinants and reassortants of severe fever with thrombocytopenia syndrome virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28937979" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Molecular genomic characterization of tick- and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33953322" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21410387" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fever with thrombocytopenia associated with a novel bunyavirus in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22114553" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21457654" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21410394" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Truly emerging--a new disease caused by a novel virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22028437" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19017912" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Nosocomial transmission of human granulocytic anaplasmosis in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23339197" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31211156" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A Cluster of Bunyavirus-Associated Severe Fever With Thrombocytopenia Syndrome Cases in a Coastal Plain Area in China, 2015: Identification of a Previously Unidentified Endemic Region for Severe Fever With Thrombocytopenia Bunyavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33068430" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Epidemiology and Ecology of Severe Fever With Thrombocytopenia Syndrome in China, 2010‒2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28835633" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28251515" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Current status of severe fever with thrombocytopenia syndrome in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28399161" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24231186" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25762790" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25762790" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30017796" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Seroprevalence of severe fever with thrombocytopenia syndrome (SFTS) virus antibodies in humans and animals in Ehime prefecture, Japan, an endemic region of SFTS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24206586" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Severe fever with thrombocytopenia syndrome, South Korea, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28033338" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31002059" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32568054" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Human Case of Severe Fever with Thrombocytopenia Syndrome Virus Infection, Taiwan, 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32568060" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Serologic Evidence of Severe Fever with Thrombocytopenia Syndrome Virus and Related Viruses in Pakistan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32687023" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36418010" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Severe Fever with Thrombocytopenia Syndrome Virus Infection, Thailand, 2019-2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22764528" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : [Isolation, identification and characterization of SFTS bunyavirus from ticks collected on the surface of domestic animals].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22943894" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : [Survey on ticks and detection of new bunyavirus in some vect in the endemic areas of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan province].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29664718" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Transmission of Severe Fever with Thrombocytopenia Syndrome Virus by Haemaphysalis longicornis Ticks, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33535015" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Isolation of Severe Fever with Thrombocytopenia Syndrome Virus from Various Tick Species in Area with Human Severe Fever with Thrombocytopenia Syndrome Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30496158" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Multistate Infestation with the Exotic Disease-Vector Tick Haemaphysalis longicornis - United States, August 2017-September 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32800150" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Distribution of Haemaphysalis longicornis and associated pathogens: analysis of pooled data from a China field survey and global published data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33353761" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Haemaphysalis longicornis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33353761" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Haemaphysalis longicornis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30681071" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Distribution, Host-Seeking Phenology, and Host and Habitat Associations of Haemaphysalis longicornis Ticks, Staten Island, New York, USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35075994" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Rapid Spread of Severe Fever with Thrombocytopenia Syndrome Virus by Parthenogenetic Asian Longhorned Ticks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35075994" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Rapid Spread of Severe Fever with Thrombocytopenia Syndrome Virus by Parthenogenetic Asian Longhorned Ticks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31150055" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : First Recognized Human Bite in the United States by the Asian Longhorned Tick, Haemaphysalis longicornis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22135253" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28337190" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Epidemiological Characteristics and Environmental Risk Factors of Severe Fever with Thrombocytopenia Syndrome in Hubei Province, China, from 2011 to 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30500443" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Animals as amplification hosts in the spread of severe fever with thrombocytopenia syndrome virus: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30666951" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Severe Fever with Thrombocytopenia Syndrome Virus in Dogs, South Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31427690" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31366857" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A Case of Cat-to-Human Transmission of Severe Fever with Thrombocytopenia Syndrome Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32045336" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Severe Fever with Thrombocytopenia Syndrome Associated with Manual De-Ticking of Domestic Dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32186502" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28774267" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Two confirmed cases of severe fever with thrombocytopenia syndrome with pneumonia: implication for a family cluster in East China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23218674" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21955213" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Person-to-person transmission of severe fever with thrombocytopenia syndrome virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22095565" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25694652" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28397631" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Occupational Severe Fever With Thrombocytopenia Syndrome Following Needle-Stick Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31625854" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22911786" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22904342" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29317732" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The Regulation of Seventeen Inflammatory Mediators are Associated with Patient Outcomes in Severe Fever with Thrombocytopenia Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33288641" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The Nonstructural Protein NSs of Severe Fever with Thrombocytopenia Syndrome Virus Causes a Cytokine Storm through the Hyperactivation of NF-κB.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35529317" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31156641" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Severe Fever With Thrombocytopenia Syndrome Virus-Induced Macrophage Differentiation Is Regulated by miR-146.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34223910" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Propagation of Activated B Cells by In Vitro Severe Fever With Thrombocytopenia Syndrome Virus Infection of Human Peripheral Blood Mononuclear Cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35603493" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27041174" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Fatal Severe Fever with Thrombocytopenia Syndrome: An Autopsy Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25329676" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31904586" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26908283" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Bone marrow findings in severe fever with thrombocytopenia syndrome: prominent haemophagocytosis and its implication in haemophagocytic lymphohistiocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29615316" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : 18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24257618" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22665769" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28194148" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23103388" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) infections in Zhejiang Province, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22144540" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22850122" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24378074" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Severe fever with thrombocytopenia syndrome, Shandong Province, China, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27776187" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26542444" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28249810" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28348452" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30721983" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Transient Appearance of Plasmablasts in the Peripheral Blood of Japanese Patients With Severe Fever With Thrombocytopenia Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30885147" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28899841" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Severe fever with thrombocytopenia syndrome-associated encephalopathy/encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31342053" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33640568" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Invasive pulmonary aspergillosis is a frequent complication in patients with severe fever with thrombocytopenia syndrome: A retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29138019" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30054190" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31765414" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31240319" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : High Levels of Circulating Cell-free DNA Are Associated With a Poor Prognosis in Patients With Severe Fever With Thrombocytopenia Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34484214" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34960620" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36866702" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Sex differences in incidence and fatality of severe fever with thrombocytopenia syndrome: A comparative study based on national surveillance data of China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22993179" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22024488" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22643834" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for rapid detection of a new SFTS bunyavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23212930" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Development and application of a one-step real-time RT-PCR using a minor-groove-binding probe for the detection of a novel bunyavirus in clinical specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24989600" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33923720" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22263262" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : [Expression of structural and non-structural proteins of severe fever with thrombocytopenia syndrome bunyavirus].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22719874" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34712212" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Time Course of Severe Fever With Thrombocytopenia Syndrome Virus and Antibodies in Patients by Long-Term Follow-Up Study, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29293899" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Differentiation of Severe Fever With Thrombocytopenia Syndrome From Scrub Typhus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30782137" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Severe fever with thrombocytopenia syndrome: comparison with scrub typhus and clinical diagnostic prediction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27019406" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Candidatus Rickettsia tarasevichiae Infection in Eastern Central China: A Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35921459" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : A Zoonotic Henipavirus in Febrile Patients in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23965284" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27303697" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30365543" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33617533" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33859168" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34563924" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27767909" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Severe Fever with Thrombocytopenia Syndrome in Patients Suspected of Having Scrub Typhus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31549609" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Coinfection of Severe Fever with Thrombocytopenia Syndrome and Scrub Typhus in Patients with Tick-Borne Illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33755004" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Co-infection with Severe Fever with Thrombocytopenia Syndrome Virus and Rickettsia japonica after Tick Bite, Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33755004" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Co-infection with Severe Fever with Thrombocytopenia Syndrome Virus and Rickettsia japonica after Tick Bite, Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28541003" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Effect of Early Plasma Exchange on Survival in Patients with Severe Fever with Thrombocytopenia Syndrome: A Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28271646" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Two Treatment Cases of Severe Fever and Thrombocytopenia Syndrome with Oral Ribavirin and Plasma Exchange.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29117665" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36736960" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Steroid pulse therapy for severe fever with thrombocytopenia syndrome patients may not improve prognosis: Retrospective analysis with overlap weighting using a national inpatient database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33606699" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33925061" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34200385" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36991571" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29355730" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Extensive severe fever with thrombocytopenia syndrome virus contamination in surrounding environment in patient rooms.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
